Showing results (1-10 of 18) with videos related to
Sort By:
Pageof 2
Clinical Reviews in Bone and Mineral Metabolism|July 3, 2018
GLUCOCORTICOID EXCESS IN BONE AND MUSCLEAmy Y Sato, Munro Peacock, Teresita BellidoBone|October 16, 2016
Role and mechanism of action of sclerostin in boneJesus Delgado-Calle, Amy Y Sato, Teresita BellidoBone|December 24, 2014
Prevention of glucocorticoid induced-apoptosis of osteoblasts and osteocytes by protecting against endoplasmic reticulum (ER) stress in vitro and in vivo in female miceAmy Y Sato, Xiaolin Tu, Kevin A McAndrews, et al.Endocrinology|May 14, 2019
Glucocorticoid-Induced Bone Fragility Is Prevented in Female Mice by Blocking Pyk2/Anoikis SignalingAmy Y Sato, Meloney Cregor, Kevin McAndrews, et al.Plos One|September 23, 2014
Raloxifene prevents skeletal fragility in adult female Zucker Diabetic Sprague-Dawley ratsKathleen M Hill Gallant, Maxime A Gallant, Drew M Brown, et al.Journal of Medicinal Chemistry|November 14, 2024
Generation of BT-Amide, a Bone-Targeted Pyk2 Inhibitor, Effective via Oral Administration, for the Prevention of Glucocorticoid-Induced Bone LossXiuqi Wang, Amy Y Sato, Silvia Marino, et al.NPJ Regenerative Medicine|October 20, 2022
Myogenic tissue nanotransfection improves muscle torque recovery following volumetric muscle lossAndrew Clark, Subhadip Ghatak, Poornachander Reddy Guda, et al.Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|May 11, 2016
Protection From Glucocorticoid-Induced Osteoporosis by Anti-Catabolic Signaling in the Absence of Sost/SclerostinAmy Y Sato, Meloney Cregor, Jesus Delgado-Calle, et al.Bone|February 15, 2024
Abaloparatide is more potent than teriparatide in restoring bone mass and strength in type 1 diabetic male miceSilvia Marino, Serra Ucer Ozgurel, Kevin McAndrews, et al.Bone Research|April 19, 2023
Reversal of the diabetic bone signature with anabolic therapies in miceSilvia Marino, Nisreen Akel, Shenyang Li, et al.Pageof 2